Innovative Treatment BFKW LLC has developed the Full Sense™ Device, a groundbreaking minimally invasive bariatric solution that may replace traditional surgical procedures for obesity, presenting a significant market opportunity in the medical device sector targeting weight loss treatments.

Strong IP Portfolio With patents granted or pending in major markets including the US, EU, Australia, China, and Russia, BFKW has solid intellectual property protection, reducing competitive risks and making their device an attractive option for expansion into global healthcare markets.

Funding and Growth Having secured $12 million in funding and raised over $2 million for clinical trials, BFKW is positioned for subsequent stages of development and commercialization, opening opportunities for investors and distribution partnerships worldwide.

Market Validation Preclinical and early human studies showing successful implantation in over 50 patients with no non-responders and superior weight loss results than existing surgical options highlight the device’s potential for rapid adoption in obesity management clinics.

Technology Stack Utilizing cloud-based services such as AWS, analytics tools like Google Analytics, and website builders, BFKW demonstrates a modern approach to operations and digital outreach, indicating readiness for engaging potential partners, clinicians, and investors in a digital environment.